Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Life Sciences Fund II L. P. Accipiter currently holds 1,581,113 shares of EMAGEON INC (EMAG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Life Sciences Fund II L. P. Accipiter has been a net buyer of EMAG stock. They have purchased $3.8M and sold $1.1M worth of shares.
Life Sciences Fund II L. P. Accipiter's most recent insider trade was on Dec 23, 2009, when they purchased 381,174 shares at $1.59 per share.
Life Sciences Fund II L. P. Accipiter serves as Executive at EMAGEON INC (EMAG). They have executed 32 insider transactions totaling $4.9M over their tenure at the company.
Life Sciences Fund II L. P. Accipiter holds the position of Executive at EMAGEON INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Life Sciences Fund II L. P. Accipiter has shown a buying trading pattern, with $3.8M in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Life Sciences Fund II L. P. Accipiter was on Dec 23, 2009, when they purchased $1.8M worth of ORCH shares. This transaction involved 1,113,258 shares at $1.58 per share.
Life Sciences Fund II L. P. Accipiter currently owns 1,581,113 shares of EMAGEON INC (EMAG), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Life Sciences Fund II L. P. Accipiter's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Life Sciences Fund II L. P. Accipiter has 32 Form 4 filings on record as an insider at EMAGEON INC.
Set alerts for Life Sciences Fund II L. P. Accipiter and 40,000+ other insiders.